858
Participants
Start Date
February 28, 2014
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Placebo
Once daily, matching placebo capsules, orally
Idalopirdine
Once daily, encapsulated tablets, orally
US338, Phoenix
US342, Fayetteville
US322, Anaheim
US305, Carson
US346, Costa Mesa
US327, Fullerton
US315, Lomita
US351, Oceanside
US307, Redlands
US301, Santa Rosa
US337, New London
US332, Stamford
US308, Delray Beach
US320, Hallandale
US347, Hialeah
US340, Lake Worth
US303, Miami
US313, Miami
US335, Naples
US345, Orange City
US309, Palm Beach Gardens
US302, Sunrise
US304, Atlanta
US360, Augusta
US318, Decatur
US334, Lake Charles
US350, Belmont
US344, Boston
US310, Saint Paul
US321, Hattiesburg
US330, Creve Coeur
US339, Paterson
US312, Staten Island
US316, Charlotte
US336, Winston-Salem
US323, Cincinnati
US349, Cleveland
US306, Columbus
US352, Lakewood
US333, Oklahoma City
US314, Allentown
US324, Pittsburgh
US341, Pittsburgh
US325, Reading
US319, Port Royal
US356, Cordova
US343, Fort Worth
US354, Houston
AR303, Banfield
AR312, Buenos Aires
AR301, Ciudad Autonoma Buenos Aires
AR304, Ciudad Autonoma Buenos Aires
AR308, Ciudad Autonoma Buenos Aires
AR311, Ciudad Autonoma Buenos Aires
AR313, Ciudad Autonoma Buenos Aires
AR314, Ciudad Autonoma Buenos Aires
AR315, Ciudad Autonoma Buenos Aires
AR307, Córdoba
AR309, Córdoba
AR305, Godoy Cruz
AR310, Mendoza
AR302, Santa Fe
AR306, Santiago del Estero
BR307, Curitiba
BR309, Curitiba
BR301, Rio de Janeiro
BR306, Rio de Janeiro
BR308, São Paulo
CA301, Halifax
CA302, Kelowna
CA306, Montreal
CA304, Qubec
CA303, Sherbrooke
CA305, Toronto
HR304, Zabok
HR301, Zagreb
HR302, Zagreb
HR303, Zagreb
CZ305, Brno
CZ306, Choceň
CZ309, Choceň
CZ308, Pardubice
CZ301, Prague
CZ303, Prague
CZ304, Prague
CZ307, Prague
CZ310, Praha 10 - Strasnice
CZ302, Rychnov nad Kněžnou
EE301, Tallinn
EE303, Tallinn
EE302, Tartu
FI302, Kuopio
FI303, Oulu
FI301, Turku
FR301, Bordeaux
FR308, Bron
FR307, Colmar
FR304, Dijon
FR309, Élancourt
FR302, Marseille
FR303, Nice
FR306, Reims
FR305, Rouen
HU304, Budapest
HU305, Budapest
HU301, Esztergom
HU303, Győr
HU302, Szeged
IE301, Cork
IL302, Haifa
IL303, Holon
IL304, Ramat Gan
IT306, Brescia
IT309, Brescia
IT311, Genova
IT312, Monza
IT302, Naples
IT313, Palermo
IT307, Perugia
IT301, Pisa
IT305, Roma
IT308, Roma
IT304, Torino
IT310, Torrette
LT302, Kaunas
LT303, Kaunas
LT301, Vilnius
LT304, Vilnius
PL301, Bialystok
PL304, Bydgoszcz
PL308, Gdynia
PL309, Krakow
PL302, Lodz
PL310, Lubin
PL306, Lublin
PL307, Oświęcim
PL303, Poznan
PT301, Amadora
PT302, Coimbra
KR303, Busan
KR301, Incheon
KR308, Seongnam-si
KR302, Seoul
KR304, Seoul
KR305, Seoul
KR306, Seoul
KR307, Seoul
KR309, Seoul
TW301, Kaohsiung City
TW302, Kaohsiung City
TW303, Taichung
TW304, Taipei
TW305, Taipei
GB307, Amersham
GB301, Glasgow
GB303, London
GB308, London
GB306, Plymouth
GB305, Preston
GB304, Southampton
GB302, Swindon
GB309, Warrington
Collaborators (1)
Otsuka Pharmaceutical Co., Ltd.
INDUSTRY
H. Lundbeck A/S
INDUSTRY